Head Office

Dendrite and IFSO publish 6th IFSO Global Registry Report

6th IFSO Global Registry Report The Sixth IFSO Global Registry Report (2021) has been published by Dendrite Clinical Systems, under the auspices of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). The publication reports data from 50 countries on over 507,290 operations including baseline obesity-related disease, operation types, operative outcomes and disease status after bariatric surgery.

9 November 2021

Dendrite establishes National Bariatric Surgery Registry in Saudi Arabia

KSA bariatric registry logo Dendrite Clinical Systems and Professor Khalid Ali Al-Rubeaan, Director of the Research and Scientific Center at the Sultan Bin Abdulaziz Humanitarian City hospital, Saudi Arabia, have established the Saudi National Bariatric Surgery Registry (SNBR) in the country. The purpose of the Registry is to collect information on bariatric procedures in the country so researchers can use the data to improve outcomes.

15 August 2021

Dendrite Clinical Systems and BSACI publish First BSACI Registry for Immunotherapy Report

BRIT Report Dendrite Clinical Systems and the British Society for Allergy & Clinical Immunology () have published the ‘First BSACI Registry for Immunotherapy Report (2020)’. The report is believed to be the first national registry report that has collected, analysed and documented the outcomes for patients receiving allergen immunotherapy to aeroallergens and venom, as well as omalizumab for chronic urticaria, anywhere in the world.

21 June 2021

CoviDiab project seeking to provide evidence on relationship between COVID-19 and diabetes

Covidiab logo

An international team of scientists are investigating a possible curious bi-directional relationship between COVID-19 and diabetes. The researchers, who are part of the CoviDiab project, have hypothesised that the SARS-CoV-2 infection maybe be triggering the onset of diabetes, and they have established a global registry to track occurrence of events and are calling for doctors around the world to contribute reports of cases of new-onset diabetes associated with COVID-19.

24 March 2021

Dendrite Clinical Systems Ltd and Device Access UK collaboration helping MedTech companies to expedite UK NICE approvals and reimbursement

For nearly a decade, Dendrite Clinical Systems and Device Access UK have been combining their expertise in clinical registries and market access and reimbursement, respectively, to expedite the regulatory processes for MedTech companies to get their technologies to patients. Working in conjunction with small, medium and large multinational companies, the partnership has enabled clients to record, collect and analyse real-world evidence and present data that adheres to the necessary regulatory guidance and requirements.

12 February 2021

Dendrite Clinical Systems’ innovative “Intellect Web” software collecting COVID-19 data

Dendrite Clinical Systems’ innovative “Intellect Web” software has been utilised by several national and international organisations to establish web-based registries to collect data from patients with COVID-19.

21 January 2021

Sales, Finance & Administration		National Registries & Support
Phone	+44 1491 411 288	Phone	+44 1491 411 288
Fax	+44 1491 411 377	CTS	https://nscts.e-dendrite.com
E-mail	info@e-dendrite.com sales@e-dendrite.com finance@e-dendrite.com	E-mail	national-support@e-dendrite.com
International Support Telephone Numbers		Australia	+61 75 613 2073
		New Zealand	Auckland: +64 9887 0919
			Christchurch: +64 366 949 50

Dr Peter K. H. Walton

Managing Director
Dendrite Clinical Systems Ltd
The Hub, Station Road
Henley-on-Thames
Oxfordshire RG9 1AY
United Kingdom

Map